Le Lézard
Classified in: Health
Subject: CPG

Holiday season and weather - TYPE O+ AND O- BLOOD DONORS: HÉMA-QUÉBEC NEEDS YOU!


MONTRÉAL, Jan. 11, 2024 /CNW/ - Héma-Québec is calling for donations in the next few days from people with type O+ and O- blood. Blood donations are often down during the holiday season, while demand for blood from hospitals is up. Though Héma?Québec has a solid blood supply overall, the need for donations from these two blood types has grown in the last few days, as many potential donors have cancelled their appointments due to the weather.

Héma-Québec is asking anyone who is unable to attend a scheduled appointment to please cancel it to free up their spot for someone else. Héma-Québec will also be as flexible as possible to accommodate walk?ins from type O+ and O- donors, whether at a donor centre or at a blood drive. One blood donation can save up to three lives, so every drop counts.

To book an appointment, visit jedonne.hema-quebec.qc.ca or call 1?800?343?7264 (SANG). If you want to make sure you are eligible to donate before coming in, visit Héma?Québec's website or call Donor Services at 1?800?847?2525.

About Héma-Québec

Héma-Québec's mission is to efficiently meet the Québec population's needs for blood and other high-quality biological products of human origin. Héma-Québec has over 1,600 employees, more than 200,000 donors of blood, stem cells, mother's milk and human tissues, as well as thousands of blood drive volunteers. Every year, Héma-Québec delivers nearly 800,000 biological products of human origin to Québec's hospitals in order to meet patients' needs.

Give blood. Give life.

www.hema-quebec.qc.ca

SOURCE Héma-Québec


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: